Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders

International Journal of Hematology

Volumn 78, Issue 2, 2003, Pages 139-145

  Atichartakarn, Vichai ^a   Likittanasombat, Khanchit ^a   Chuncharunee, Suporn ^a   Chandanamattha, Pakorn ^a   Worapongpaiboon, Surapon ^a   Angchaisuksiri, Pantep ^a   Aryurachai, Katcharin ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Pulmonary hypertension; Splenectomy; Thalassemia

Indexed keywords

BETA2 THROMBOGLOBULIN; FERRITIN; GLOBULIN; THROMBIN ANTITHROMBIN COMPLEX; UNCLASSIFIED DRUG;

ADULT; ANEMIA; ARTICLE; BETA THALASSEMIA; CLINICAL ARTICLE; CLINICAL FEATURE; ECHOCARDIOGRAPHY; ERYTHROCYTE COUNT; FEMALE; FERRITIN BLOOD LEVEL; HEART CATHETERIZATION; HEART LEFT VENTRICLE CONTRACTION; HEMODYNAMICS; HUMAN; HYPERCOAGULABILITY; LUNG ANGIOGRAPHY; LUNG ARTERY PRESSURE; LUNG VASCULAR RESISTANCE; MALE; PULMONARY HYPERTENSION; SPLENECTOMY; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; THROMBOCYTOSIS;

EID: 0042890574     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02983382     Document Type: Article

References (55)

1. Rich S. Pulmonary hypertension. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 2001:1908-1935.
2. Sonakul D, Pacharee P, Laohapand T, Fucharoen S, Wasi P. Pulmonary artery obstruction in thalassemia. Southeast Asian J Trop Med Public Health. 1980;11:516-523.
3. Sonakul D, Fucharoen S. Pulmonary thromboembolism in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992; 23(suppl 2):25-28.
4. Borgna-Pignatti C, Carnelli V, Caruso V, et al. Thromboembolic events in beta thalassemia major: an Italian multicenter study. Acta Haematol. 1998;99:76-79.
5. Cappellini MD, Robbiolo L, Bottasso BM, et al. Venous thromboembolism and hypercoagulability in splenectomized patients with thalassaemia intermedia. Br J Haematol. 2000;111:467-473.
6. Oh JK, Seward JB, Tajik AJ. Pulmonary hypertension. In: Oh JK, Seward JB, Tajik AJ, eds. The Echo Manual. Philadelphia: Lippincott Williams & Wilkins; 1999:215-222.
7. Oh JK, Seward JB, Tajik AJ. Assessment of ventricular systolic function. In: Oh JK, Seward JB, Tajik AJ, eds. The Echo Manual. Philadelphia: Lippincott Williams & Wilkins; 1999:37-44.
8. Peterson KL, Fred HL, Alexander JK. Pulmonary arterial web: a new angiographic sign of previous thromboembolism. N Engl J Med. 1967;277:33-35.
9. Grossman W. Blood flow measurement: the cardiac output and vascular resistance. In: Baim DS, Grossman W, eds. Grossman's Cardiac Catheterization, Angiography and Intervention. Philadelphia: Lippincott Williams & Wilkins; 2000:159-178.
10. Pelzer H, Schwarz A, Heimburger N. Determination of human thrombin-antithrombin III complex in plasma with an enzymelinked immunosorbent assay. Thromb Haemost. 1988;59:101-106.
11. Pelzer H, Schwarz A, Stuber W. Determination of human prothrombin activation fragment 1+2 in plasma with an antibody against a synthetic peptide. Thromb Haemost. 1991;65:153-159.
12. 2-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood. 1981;57:199-202.
13. Ellis BC, Stransky A. A quick and accurate method for the determination of fibrinogen in plasma. J Lab Clin Med. 1961;58:477-488.
14. Kutlar A, Kutlar F, Wilson JB, Headlee MG, Huisman TH. Quantitation of hemoglobin components by high performance cationexchange liquid chromatography. Am J Hematol. 1984;17:39-53.
15. Forman DT, Parker SL. The measurement and interpretation of serum ferritin. Ann Clin Lab Sci. 1980;10:345-350.
16. Buri PS, Hathirat S, Watthanakaset S, Na Ranong W. Weight and height in normal Thai adult. Thai Med Counc Bull. 1983;12:409-414.
17. Weatherall DJ. The thalassemias. In: Beutler E, Lichtman MA, Coller BS, Kipps TJ, Seligsohn U, eds. Hematology. New York: McGraw-Hill; 2001:547-580.
18. Pattanapanyasat K, Thepthai C, Lamchiagdhase P, et al. Lymphocyte subsets and specific T-cell immune response in thalassemia. Cytometry. 2000;42:11-17.
19. Pootrakul P, Kitcharoen K, Yansukon P, Anuwatanakulchai M, Thuvassethakul P, Wasi P. The effect of erythroid hyperplasia on iron balance. Blood. 1988;71:1124-1129.
20. Rich S, Brundage BH. Pulmonary hypertension: a cellular basis for understanding the pathophysiology and treatment. J Am Coll Cardiol. 1989;14:545-550.
21. Stone RM, Bridges KR, Libby P. Hematological-oncological disorders and cardiovascular disease. In: Braunwald E, Zipes DP, Libby P, eds. Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 2001:2223-2243.
22. Andrews NC. Disorders of iron metabolism. N Engl J Med. 1999; 341:1986-1995.
23. Lau KC, Li AMC, Hui PW, Yeung CY. Left ventricular function in β-thalassaemia major. Arch Dis Child. 1989;64:1046-1051.
24. Gibbs JSR, Higenbottam TW. Recommendations on the management of pulmonary hypertension in clinical practice. Heart. 2001; 86(suppl I):i1-i13.
25. Kay JM. Vascular disease. In: Thurlbeck WM, Churg AM, eds. Pathology of the Lung. New York: Thieme Medical Publishers; 1995: 931-1066.
26. Eldor A, Durst R, Hy-Am E, et al. A chronic hypercoagulable state in patients with β-thalassemia major is already present in childhood. Br J Haematol. 1999;107:739-746.
27. Zwaal RFA, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89: 1121-1132.
28. Borenstain-Ben Yashar V, Barenholz Y, Hy-Am E, Rachmilewitz EA, Eldor A. Phosphatidylserine in the outer leaflet of red blood cells from beta-thalassemia patients may explain the chronic hypercoagulable state and thrombotic episodes. Am J Hematol. 1993;44: 63-65.
29. Helley D, Eldor A, Girot R, Ducrocq R, Guillin MC, Bezeaud A. Increased procoagulant activity of red blood cells from patients with homozygous sickle cell disease and β-thalassemia. Thromb Haemost. 1996;76:322-327.
30. Srinivasan PT, Basu J. Altered membrane phospholipid organization and erythrophagocytosis in E β-thalassemia. Biochim Biophys Acta. 1996;1285:65-70.
31. Atichartakarn V, Angchaisuksiri P, Aryurachai K, et al. Relationship between hypercoagulable state and erythrocyte phosphatidylserine exposure in splenectomized haemoglobin E/β-thalassaemic patients. Br J Haematol. 2002;118:893-898.
32. Rodriguez-Erdman F, Naimi S. Studies on the pathogenesis of the generalized Shwartzman reaction. Thromb Diath Haemor. 1967;17: 156-164.
33. Lee L. Reticuloendothelial clearance of circulating fibrin in the pathogenesis of the generalized Shwartzman reaction. J Exp Med. 1962;15:1065-1082.
34. Shirahata A, Funahara Y, Opartkiattikul N, Fucharoen S, Laosombat V, Yamada K. Protein C and protein S deficiency in thalassemic patients. Southeast Asian J Trop Med Public Health. 1992; 23(suppl 2):65-73.
35. O'Driscoll A, Mackie IJ, Porter JB, Marchin SJ. Low plasma heparin cofactor II levels in thalassaemia syndromes are corrected by chronic blood transfusion. Br J Haematol. 1995;90:65-70.
36. Brass LF, Ahuja M, Belmonte E, Pizarro S, Tarver A. Hoxie JA. The human platelet thrombin receptor: turning it on, turning it off. Ann N Y Acad Sci. 1994;714:1-12.
37. Tracy PB. Role of platelets and leukocytes in coagulation. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis: Basic Principles & Clinical Practice. Philadelphia: Lippincott Williams & Wilkins; 2001:575-596.
38. Rostagno C, Prisco D, Abbate R, Poggesi L. Pulmonary hypertension associated with long-standing thrombocytosis. Chest. 1991;99: 1303-1305.
39. Kisanuki A, Kietthubthew S, Asada Y, Marutsuka K, Funahara Y, Sumiyoshi A. Intravenous injection of sonicated blood induces pulmonary microthromboembolism in rabbits with ligation of the splenic artery. Thromb Res. 1997;85:95-103.
40. Hoeper MM, Niedermeyer J, Hoffmeyer F, Flemming P, Fabel H. Pulmonary hypertension after splenectomy? Ann Intern Med. 1999; 130:506-509.
41. Hovav T, Goldfarb A, Artmann G, Yedgar S, Barshtein G. Enhanced adherence of beta-thalassaemic erythrocytes to endothelial cells. Br J Haematol. 1999;106:178-181.
42. Closse C, Dachary-Prigent J, Boisseau MR. Phosphatidylserinerelated adhesion of human erythrocytes to vascular endothelium. Br J Haematol. 1999;107:300-302.
43. Vordermeier S, Singh S, Biggerstaff J, et al. Red blood cells from patients with sickle cell disease exhibit an increased adherence to cultured endothelium pretreated with tumor necrosis factor. Br J Haematol. 1992;81:591-597.
44. Wanachiwanawin W. Infections in thalassemia. In: Pansatiankul B, ed. Proceedings of the 7th International Conference on Thalassemia and the Haemoglobinopathies, Bangkok, Thailand, 31 May-4 June 1999. 1999:162, S1104.
45. Aswapokee P, Aswapokee N, Fucharoen S, Sukroongreung S, Wasi P. Severe infection in thalassemia: a prospective study. Birth Defects. 1988;23:521-526.
46. Rich S, Levitsky S, Brundage BH. Pulmonary hypertension from chronic pulmonary thromboembolism. Ann Intern Med. 1988;108: 425-434.
47. Butthep P, Bunyaratvej A, Funahara Y, et al. Alterations in vascular endothelial cell-related plasma proteins in thalassaemic patients and their correlation with clinical symptoms. Thromb Haemost. 1995;74:1045-1049.
48. Aessopos A, Stamatelos G, Skoumas V, Vassilopoulos G, Mantzourani M, Loukopoulos D. Pulmonary hypertension and right heart failure in patients with β-thalassemia intermedia. Chest. 1995;107:50-53.
49. Aessopos A, Farmakis D, Karagiorga M, et al. Cardiac involvement in thalassemia intermedia: a multicenter study. Blood. 2001;97: 3411-3416.
50. Du ZD, Roguin N, Milgram E, Saab K, Koren A. Pulmonary hypertension in patients with thalassemia major. Am Heart J. 1997;134: 532-537.
51. Sonakul D, Pacharee P, Wasi P, Fucharoen S. Cardiac pathology in 47 patients with beta thalassemia/haemoglobin E. Southeast Asian J Trop Med Public Health. 1984;15:554-563.
52. Wasi P. Hemoglobinopathies including thalassemia. Clin Haematol. 1981;10:707-729.
53. Schrier SL. Pathophysiology of the thalassemias. West J Med. 1997; 167:82-89.
54. Morse JH, Barst RJ, Itescu S, et al. Primary pulmonary hypertension in HIV infection: an outcome determined by particular HLA class II alleles. Am J Respir Crit Care Med. 1996;53:1299-1301.
55. Voelkel NF, Tuder RM. Cellular and molecular mechanisms in the pathogenesis of severe pulmonary hypertension. Eur Respir J. 1995; 8:2129-2138.